Medovate is a medical device company dedicated to the development and commercialisation of innovative medical technologies created within the NHS.
Medovate provides technical, management and financial support to develop medical devices through clinical trials, regulatory approval and market launch, in order to benefit patient care and healthcare delivery.
Medovate’s current pipeline of medical technologies is focussed on anaesthesia, critical care and surgery.Read More
Medovate’s project pipeline is fed through its UK network of NHS researchers and research organisations. As the 5th largest employer in the world, the NHS is a significant innovator of medical technology solutions with the potential to create real value and impact by addressing unmet clinical needs.
Medovate’s network also includes its NHS innovation hub partner, Health Enterprise East, who annually review over 200 early stage commercial opportunities which might be suitable for protection and development as high value medtech products. Health Enterprise East have a 12-year track record supporting medtech innovation.
Medovate’s current innovation pipeline focus is on intensive care, anaesthesia and surgical products.
Medovate is an innovation development company dedicated to bringing novel medical technologies to market.